This trial tests a new treatment called IMSA101, which is injected directly into tumors. It is sometimes used with another drug that helps the immune system fight cancer. The study focuses on patients whose tumors can be accessed for these injections. The goal is to see if this approach can effectively shrink tumors and improve patient outcomes.